# Randomised Control Trial for Improving Functional Outcome From Stroke in End Stage Renal Disease Patients

Study · id `cardio:ct-nct01656213` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01656213](<https://clinicaltrials.gov/study/NCT01656213>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01656213

Browse, organ or system: Brain; Kidneys  
Browse, condition area: Stroke; Kidney connections  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 110 participants.

## Technical summary

Registry record NCT01656213. Randomized; single masking; primary purpose treatment. Start 2012-07 (registry gives no type); primary completion 2014-07 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 110 participants (enrolled count; ClinicalTrials.gov record NCT01656213, source copy `cardio:ctgov-nct01656213-2016-02-17`, retrieved 2026-10-26)
- Start date: 2012-07 (registry gives no type) (ClinicalTrials.gov record NCT01656213, source copy `cardio:ctgov-nct01656213-2016-02-17`, retrieved 2026-10-26)
- Primary completion: 2014-07 (actual) (ClinicalTrials.gov record NCT01656213, source copy `cardio:ctgov-nct01656213-2016-02-17`, retrieved 2026-10-26)
- Completion: 2014-07 (actual) (ClinicalTrials.gov record NCT01656213, source copy `cardio:ctgov-nct01656213-2016-02-17`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT01656213, source copy `cardio:ctgov-nct01656213-2016-02-17`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01656213-2016-02-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: Randomised Control Trial for Improving Functional Outcome From Stroke in End Stage Renal Disease Patients
- Condition: Stroke
- Condition: End Stage Renal Disease
- Intervention (Device): Computer-based target pursuit task (created using E-Prime software) and visual-feedback handgrip force transducer (CurrentDesigns 2012).
- Lead sponsor: Imperial College London
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Imperial College London (`cardio:org-imperial-college-london`)

## Provenance

Content hash: 47cfcb0b8c6155e96cf0bb538d3869ceac9680c3c5da19fbd703060a5c4e57f9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
